CIEBH’s research leadership group is helping build Canada’s capacity to rapidly develop new technologies based on engineering immune responses from fundamental science through to biomanufacturing, regulatory science, and clinical trials.
Importantly, CIEBH is committed to breaking down the disciplinary, institutional, and sector silos that have long-characterized the translational pipeline through the active engagement of a diverse range of stakeholders in the earliest stages of the translational process, including: researchers, patients, care providers, social scientists, health authorities, policy makers, and public health, clinical trials, regulatory, manufacturing, and commercialization experts.
Anna Blakney, PhD
Assistant Professor, School of Biomedical Engineering
Michael Smith Laboratories
The University of British Columbia
Nadine Caron, O.B.C., MD, MPH, FRCSC
First Nations Health Authority Chair in Cancer and Wellness
Professor, Department of Surgery
Co-Director, Centre for Excellence in Indigenous Health
The University of British Columbia
Pieter Cullis, O.C., PhD, FRSC, FNAI
Professor of Biochemistry & Molecular Biology
The University of British Columbia
Co-Founder and Chairman, Acuitas Therapeutics
Co-Founder and Chairman, NanoVation Therapeutics
Scott Halperin, MD
Professor of Pediatrics and Microbiology & Immunology
Director, Canadian Centre for Vaccinology
Dalhousie University
Megan Levings, PhD
Professor of Surgery and Biomedical Engineering
The University of British Columbia
Lead, Childhood Diseases Theme
BC Children’s Hospital Research Institute
James Piret, ScD
Professor of Chemical and Biological Engineering
Michael Smith Laboratories
The University of British Columbia
Sriram Subramaniam, PhD
Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design
Professor of Biochemistry & Molecular Biology
The University of British Columbia
Founder and CEO, Gandeeva Therapeutics
Carolina Tropini, PhD
Assistant Professor of Microbiology & Immunology and Biomedical Engineering
The University of British Columbia
Peter Zandstra, C.M., PhD, FCAHS, FRSC
Canada Research Chair in Stem Cell Bioengineering
Professor and Founding Director, School of Biomedical Engineering
Director, Michael Smith Laboratories
The University of British Columbia
Chief Scientific Officer, CCRM